Literature DB >> 32851459

Nontargeted lipidomics of novel human plasma reference materials: hypertriglyceridemic, diabetic, and African-American.

Juan J Aristizabal-Henao1, Christina M Jones2, Katrice A Lippa2, John A Bowden3.   

Abstract

The unavailability of appropriate quality assurance/quality control materials in many lipidomics applications poses a significant challenge for lipidomics research. It is recommended that samples with certified values and/or consensus estimates, such as NIST SRM 1950-Metabolites in Frozen Human Plasma, be implemented in routine analyses to enable community-wide comparisons of lipidomics results and analytical workflows. Herein, we applied a nontargeted lipidomics method for the analysis of a new human plasma reference material suite developed by NIST (hypertriglyceridemic, diabetic, and African-American plasma pools), in addition to SRM 1950. We identified specific lipidomics fingerprints associated with each sample type, including lauric acid-containing lipids and elevated triacylglycerol levels in hypertriglyceridemic plasma, palmitoleic acid-containing lipids in diabetic plasma, and oxidized fatty acid-containing phospholipids in African-American plasma. This work highlights the importance of developing and profiling application-specific reference materials, while establishing reference data that may be used for system suitability and/or quality control metrics.Graphical abstract.

Entities:  

Keywords:  Analytical chemistry; Lipidomics; Mass spectrometry; Plasma; Quality control; Reference materials

Mesh:

Substances:

Year:  2020        PMID: 32851459     DOI: 10.1007/s00216-020-02910-3

Source DB:  PubMed          Journal:  Anal Bioanal Chem        ISSN: 1618-2642            Impact factor:   4.142


  4 in total

1.  What if using certified reference materials (CRMs) was a requirement to publish in analytical/bioanalytical chemistry journals?

Authors:  Stephen A Wise
Journal:  Anal Bioanal Chem       Date:  2022-06-13       Impact factor: 4.478

2.  Clinical lipidomics - A community-driven roadmap to translate research into clinical applications.

Authors:  Olga Vvedenskaya; Michal Holčapek; Michael Vogeser; Kim Ekroos; Peter J Meikle; Anne K Bendt
Journal:  J Mass Spectrom Adv Clin Lab       Date:  2022-02-07

3.  Cross-Laboratory Standardization of Preclinical Lipidomics Using Differential Mobility Spectrometry and Multiple Reaction Monitoring.

Authors:  Mohan Ghorasaini; Yassene Mohammed; Jerzy Adamski; Lisa Bettcher; John A Bowden; Matias Cabruja; Kévin Contrepois; Mathew Ellenberger; Bharat Gajera; Mark Haid; Daniel Hornburg; Christie Hunter; Christina M Jones; Theo Klein; Oleg Mayboroda; Mina Mirzaian; Ruin Moaddel; Luigi Ferrucci; Jacqueline Lovett; Kenneth Nazir; Mackenzie Pearson; Baljit K Ubhi; Daniel Raftery; Fabien Riols; Rebekah Sayers; Eric J G Sijbrands; Michael P Snyder; Baolong Su; Vidya Velagapudi; Kevin J Williams; Yolanda B de Rijke; Martin Giera
Journal:  Anal Chem       Date:  2021-12-03       Impact factor: 6.986

Review 4.  Reference materials for MS-based untargeted metabolomics and lipidomics: a review by the metabolomics quality assurance and quality control consortium (mQACC).

Authors:  Katrice A Lippa; Juan J Aristizabal-Henao; Richard D Beger; John A Bowden; Corey Broeckling; Chris Beecher; W Clay Davis; Warwick B Dunn; Roberto Flores; Royston Goodacre; Gonçalo J Gouveia; Amy C Harms; Thomas Hartung; Christina M Jones; Matthew R Lewis; Ioanna Ntai; Andrew J Percy; Dan Raftery; Tracey B Schock; Jinchun Sun; Georgios Theodoridis; Fariba Tayyari; Federico Torta; Candice Z Ulmer; Ian Wilson; Baljit K Ubhi
Journal:  Metabolomics       Date:  2022-04-09       Impact factor: 4.747

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.